{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:06:15Z","timestamp":1760299575327},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-17-0311","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T22:06:11Z","timestamp":1492121171000},"page":"642-644","source":"Crossref","is-referenced-by-count":3,"title":["Tolvaptan, Is It a Trump to Worsening Renal Function?"],"prefix":"10.1253","volume":"81","author":[{"given":"Shin-ichi","family":"Momomura","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Jichi Medical University Saitama Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. <i>J Am Coll Cardiol<\/i> 2009; 53: 589\u2013596.","DOI":"10.1016\/j.jacc.2008.05.068"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. <i>Eur J Heart Fail<\/i> 2008; 10: 188\u2013195.","DOI":"10.1016\/j.ejheart.2008.01.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. <i>Am Heart J<\/i> 2004; 147: 331\u2013338.","DOI":"10.1016\/j.ahj.2003.08.012"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Forman DE, Butler J, Wang Y, Abraham WT, O\u2019Connor CM, Gottlieb SS, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. <i>J Am Coll Cardiol<\/i> 2004; 43: 61\u201367.","DOI":"10.1016\/j.jacc.2003.07.031"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Logeart D, Tabet JY, Hittinger L, Thabut G, Jourdain P, Maison P, et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. <i>Int J Cardiol<\/i> 2008; 127: 228\u2013232.","DOI":"10.1016\/j.ijcard.2007.06.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: Activation of the neurohumoral axis. <i>Ann Intern Med<\/i> 1985; 103: 1\u20136.","DOI":"10.7326\/0003-4819-103-1-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. <i>Circulation<\/i> 2002; 105: 1348\u20131353.","DOI":"10.1161\/hc1102.105264"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE registry. <i>Cardiology<\/i> 2009; 113: 12\u201319.","DOI":"10.1159\/000164149"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. <i>Am Heart J<\/i> 2010; 160: 264\u2013271.","DOI":"10.1016\/j.ahj.2010.05.032"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. <i>Am J Cardiol<\/i> 2006; 97: 1759\u20131764.","DOI":"10.1016\/j.amjcard.2005.12.072"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. <i>JAMA<\/i> 2007; 297: 1319\u20131331.","DOI":"10.1001\/jama.297.12.1319"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Felker GM, Mentz RJ, Cole RT, Adams KF, Egnaczyk GF, Fiuzat M, et al. Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure. <i>J Am Coll Cardiol<\/i> 2017; 69: 1399\u20131406.","DOI":"10.1016\/j.jacc.2016.09.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Konstam MA, Kiernan M, Chandler A, Dhingra R, Mody FV, Eisen H, et al. Short-Term effects of tolvaptan in patients with acute heart failure and volume overload. <i>J Am Coll Cardiol<\/i> 2017; 69: 1409\u20131419.","DOI":"10.1016\/j.jacc.2016.12.035"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shirakabe A, Hata N, Yamamoto M, Kobayashi N, Shinada T, Tomita K, et al. Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure. <i>Circ J<\/i> 2014; 78: 911\u2013921.","DOI":"10.1253\/circj.CJ-13-1255"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kimura K, Momose T, Hasegawa T, Morita T, Misawa T, Motoki H, et al. Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. <i>J Cardiol<\/i> 2016; 67: 399\u2013405.","DOI":"10.1016\/j.jjcc.2015.09.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, et al. Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. <i>J Card Fail<\/i> 2016; 22: 423\u2013432.","DOI":"10.1016\/j.cardfail.2016.02.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jujo K, Saito K, Ishida I, Furuki Y, Kim A, Suzuki Y, et al. Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. <i>ESC Heart Fail<\/i> 2016; 3: 177\u2013188.","DOI":"10.1002\/ehf2.12088"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tamaki S, Sato Y, Yamada T, Morita T, Furukawa Y, Iwasaki Y, et al. Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure and preserved left ventricular ejection fraction: Prospective randomized controlled study. <i>Circ J<\/i> 2017; 81: 740\u2013747.","DOI":"10.1253\/circj.CJ-16-1122"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Matsuzaki M, Hori M, Izumi T, Fukunami M; Tolvaptan Investigators. Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: A phase III, randomized, double-blind, placebo-controlled study (QUEST study). <i>Cardiovasc Drugs Ther<\/i> 2011; 25(Suppl 1): S33\u2013S45.","DOI":"10.1007\/s10557-011-6304-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K, et al. Effectiveness and adverse events of tolvaptan in octogenarians with heart failure: Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study). <i>Int Heart J<\/i> 2015; 56: 137\u2013143.","DOI":"10.1536\/ihj.14-332"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Takei M, Kohsaka S, Shiraishi Y, Goda A, Izumi Y, Yagawa M, et al. Function for acute heart failure differs between patients with preserved and reduced ejection fraction. <i>Circ Heart Fail<\/i> 2015; 8: 527\u2013532.","DOI":"10.1161\/CIRCHEARTFAILURE.114.001734"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Watanabe K, Dohi K, Sugimoto T, Yamada T, Sato Y, Ichikawa K, et al. Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure. <i>J Cardiol<\/i> 2012; 60: 462\u2013469.","DOI":"10.1016\/j.jjcc.2012.09.002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ishikawa M, Kobayashi N, Sugiyama F, Onoda S, Ishimitsu T. Renoprotective effect of vasopressin v2 receptor antagonist tolvaptan in Dahl rats with end-stage heart failure. <i>Int Heart J<\/i> 2013; 54: 98\u2013106.","DOI":"10.1536\/ihj.54.98"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, et al. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. <i>Clin Exp Nephrol<\/i> 2009; 13: 438\u2013446.","DOI":"10.1007\/s10157-009-0196-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide. <i>J Clin Pharmacol<\/i> 2013; 53: 1277\u20131285.","DOI":"10.1002\/jcph.197"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/5\/81_CJ-17-0311\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T14:50:51Z","timestamp":1498402251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/5\/81_CJ-17-0311\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0311","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}